TRIM35-mediated degradation of nuclear PKM2 destabilizes GATA4/6 and induces P53 in cardiomyocytes to promote heart failure.
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
02 11 2022
02 11 2022
Historique:
entrez:
2
11
2022
pubmed:
3
11
2022
medline:
5
11
2022
Statut:
ppublish
Résumé
Pyruvate kinase M2 (PKM2) is a glycolytic enzyme that translocates to the nucleus to regulate transcription factors in different tissues or pathologic states. Although studied extensively in cancer, its biological role in the heart remains unresolved. PKM1 is more abundant than the PKM2 isoform in cardiomyocytes, and thus, we speculated that PKM2 is not genetically redundant to PKM1 and may be critical in regulating cardiomyocyte-specific transcription factors important for cardiac survival. Here, we showed that nuclear PKM2 (
Identifiants
pubmed: 36322626
doi: 10.1126/scitranslmed.abm3565
doi:
Substances chimiques
Apoptosis Regulatory Proteins
0
Gata4 protein, mouse
0
GATA4 Transcription Factor
0
Pyruvate Kinase
EC 2.7.1.40
Transcription Factors
0
TRIM35 protein, mouse
0
Tumor Suppressor Protein p53
0
Gata6 protein, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
eabm3565Subventions
Organisme : CIHR
Pays : Canada